Reneo Pharmaceuticals, Inc entered into a Subscription Agreement of common shares for a gross proceeds $65,000,000 on May 10, 2024.The transaction includes participation from OnKure, Inc, RADIATE MERGER SUB II, LLC and Radiate Merger Sub I, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.67 USD | -1.76% | +0.60% | +4.38% |
16/05 | Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing | MT |
13/05 | Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.38% | 5.58Cr | |
+51.85% | 5.79TCr | |
+41.42% | 4.03TCr | |
-5.25% | 3.99TCr | |
-5.16% | 2.85TCr | |
+12.79% | 2.64TCr | |
-20.18% | 1.93TCr | |
+30.88% | 1.24TCr | |
+0.61% | 1.22TCr | |
+25.06% | 1.22TCr |
- Stock Market
- Equities
- RPHM Stock
- News Reneo Pharmaceuticals, Inc.
- Reneo Pharmaceuticals, Inc. announced that it expects to receive $65 million in funding from OnKure, Inc., RADIATE MERGER SUB II, LLC, Radiate Merger Sub I, Inc